Guobing Li

5PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
Supramolecular Assembly of Stepped-Persistent ROS Nanogenerator for Sustained Tumor Immunotherapy.

|Apr 22, 2026
Gypenosides inhibit melanoma proliferation, migration and enhance the anti-tumor immunity of CD8+ T cells via ETV5/PD-L1 signaling.

|Nov 28, 2025
Blocking PCSK9 suppresses hepatocellular carcinoma immune escape by decreasing FLI1-mediated SPP1 and PD-L1 expression.

Changpeng Hu, Ming Qin, Wenjing Lai

|Aug 15, 2023
Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.

Yue Dai, Changpeng Hu, Huyue Zhou

|Apr 29, 2021
Novel role of CAP1 in regulation RNA polymerase II-mediated transcription elongation depends on its actin-depolymerization activity in nucleoplasm.

Qian Zhang, Qin Tang, Wuyi Liu

Pageof 1

Frequent Collaborators

1 joint publications

Jingbin Huang

1 joint publications

Rong Zhang

1 joint publications

Changpeng Hu

1 joint publications

Zhenqiang Wang